Jianxin Bao, PHD

With more than 30 years of research experience in neuroscience, including postdoctoral experience at Columbia, Harvard and Stanford, Dr. Bao established a broad research foundation that has enabled him to develop a unique research program to understand the molecular mechanisms underlying hearing disorders. At Gateway Biotechnology, Dr. Bao developed several animal model screens to identify drugs to prevent and treat hearing loss and tinnitus. In addition, he developed tools to quantify changes to the auditory system in humans and in animal models, including synaptic loss in the cochlea. His academic work began with a K01 award from NIH and continues at Gateway with the support of numerous NIH awards and a grant from the US Department of the Army. Through close interactions with clinicians and research scientists at both academic and industrial institutions, he expanded the scope of work to translational studies of FDA-approved drugs for the treatment of hearing loss and tinnitus.